
Shin Lin Chen
Examiner (ID: 17983, Phone: (571)272-0726 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1633, 1632 |
| Total Applications | 1467 |
| Issued Applications | 727 |
| Pending Applications | 150 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11421661
[patent_doc_number] => 20170029805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA'
[patent_app_type] => utility
[patent_app_number] => 15/303932
[patent_app_country] => US
[patent_app_date] => 2015-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 30861
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/303932 | METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA | Apr 12, 2015 | Abandoned |
Array
(
[id] => 11677134
[patent_doc_number] => 09675641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Materials and methods to enhance hematopoietic stem cells engraftment procedures'
[patent_app_type] => utility
[patent_app_number] => 14/638676
[patent_app_country] => US
[patent_app_date] => 2015-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 13288
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14638676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/638676 | Materials and methods to enhance hematopoietic stem cells engraftment procedures | Mar 3, 2015 | Issued |
Array
(
[id] => 10333516
[patent_doc_number] => 20150218520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'HAIR FOLLICLE MESENCHYMAL STEM CELLS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/618073
[patent_app_country] => US
[patent_app_date] => 2015-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5639
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14618073
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/618073 | HAIR FOLLICLE MESENCHYMAL STEM CELLS AND USE THEREOF | Feb 9, 2015 | |
Array
(
[id] => 17329210
[patent_doc_number] => 11219651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Recombinant herpes virus and pharmaceutical composition containing the same
[patent_app_type] => utility
[patent_app_number] => 14/611643
[patent_app_country] => US
[patent_app_date] => 2015-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 8707
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14611643
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/611643 | Recombinant herpes virus and pharmaceutical composition containing the same | Feb 1, 2015 | Issued |
Array
(
[id] => 10265670
[patent_doc_number] => 20150150667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'METHODS AND SYSTEM FOR MANAGING MOUSE COLONIES'
[patent_app_type] => utility
[patent_app_number] => 14/611040
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8691
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14611040
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/611040 | METHODS AND SYSTEM FOR MANAGING MOUSE COLONIES | Jan 29, 2015 | Abandoned |
Array
(
[id] => 11350502
[patent_doc_number] => 20160369242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'METHOD FOR PRODUCING INDUCED PLURIPOTENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/110979
[patent_app_country] => US
[patent_app_date] => 2015-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5037
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110979
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110979 | METHOD FOR PRODUCING INDUCED PLURIPOTENT CELLS | Jan 12, 2015 | Abandoned |
Array
(
[id] => 11129546
[patent_doc_number] => 20160326521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 15/110712
[patent_app_country] => US
[patent_app_date] => 2015-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22516
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110712
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110712 | Methods and compositions for creating altered and improved cells and organisms | Jan 8, 2015 | Issued |
Array
(
[id] => 10686106
[patent_doc_number] => 20160032251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'CHIMERIC PESTIVIRUS WITH INSERTION IN 3\' NONTRANSLATED REGION (3\' NTR) WITH STABLE REPLICATION AND RNASE RESISTANCE'
[patent_app_type] => utility
[patent_app_number] => 14/575043
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 13827
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14575043
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/575043 | CHIMERIC PESTIVIRUS WITH INSERTION IN 3' NONTRANSLATED REGION (3' NTR) WITH STABLE REPLICATION AND RNASE RESISTANCE | Dec 17, 2014 | Abandoned |
Array
(
[id] => 11872514
[patent_doc_number] => 09744264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Extracellular matrix encasement structures and methods'
[patent_app_type] => utility
[patent_app_number] => 14/571639
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 7719
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571639
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/571639 | Extracellular matrix encasement structures and methods | Dec 15, 2014 | Issued |
Array
(
[id] => 10215128
[patent_doc_number] => 20150100120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'Extracellular Matrix Encasement Structures and Methods'
[patent_app_type] => utility
[patent_app_number] => 14/571679
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7720
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571679
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/571679 | Extracellular Matrix Encasement Structures and Methods | Dec 15, 2014 | Abandoned |
Array
(
[id] => 10670863
[patent_doc_number] => 20160017008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin'
[patent_app_type] => utility
[patent_app_number] => 14/570976
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10845
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14570976
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/570976 | Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin | Dec 14, 2014 | Abandoned |
Array
(
[id] => 10274137
[patent_doc_number] => 20150159134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'METHOD FOR PRODUCING RETINAL PIGMENT EPITHELIAL CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/566184
[patent_app_country] => US
[patent_app_date] => 2014-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 23361
[patent_no_of_claims] => 134
[patent_no_of_ind_claims] => 102
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14566184
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/566184 | METHOD FOR PRODUCING RETINAL PIGMENT EPITHELIAL CELLS | Dec 9, 2014 | Abandoned |
Array
(
[id] => 11092677
[patent_doc_number] => 20160289645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)'
[patent_app_type] => utility
[patent_app_number] => 15/038446
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13873
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038446
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038446 | Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s) | Nov 20, 2014 | Abandoned |
Array
(
[id] => 11075722
[patent_doc_number] => 20160272687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'ADENO-ASSOCIATED VIRUS \"X\" ONCOGENE'
[patent_app_type] => utility
[patent_app_number] => 15/035228
[patent_app_country] => US
[patent_app_date] => 2014-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17245
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035228 | ADENO-ASSOCIATED VIRUS "X" ONCOGENE | Nov 7, 2014 | Abandoned |
Array
(
[id] => 9910312
[patent_doc_number] => 20150065514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'Methods And Compositions To Reduce Oxidative Stress'
[patent_app_type] => utility
[patent_app_number] => 14/535690
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 49639
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14535690
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/535690 | Methods and compositions to reduce oxidative stress | Nov 6, 2014 | Issued |
Array
(
[id] => 10225864
[patent_doc_number] => 20150110857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'CNS DELIVERY OF MRNA AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/521168
[patent_app_country] => US
[patent_app_date] => 2014-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 21640
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521168
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/521168 | CNS DELIVERY OF MRNA AND USES THEREOF | Oct 21, 2014 | Abandoned |
Array
(
[id] => 13107231
[patent_doc_number] => 10072249
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Method of inducing kidney from pluripotent stem cells
[patent_app_type] => utility
[patent_app_number] => 15/026462
[patent_app_country] => US
[patent_app_date] => 2014-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 33
[patent_no_of_words] => 15127
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/026462 | Method of inducing kidney from pluripotent stem cells | Oct 15, 2014 | Issued |
Array
(
[id] => 9934274
[patent_doc_number] => 20150082466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Transgenic Non-Human Vertebrate for the Expression of Class-Switched, Fully Human, Antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/498685
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24174
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498685
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/498685 | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies | Sep 25, 2014 | Issued |
Array
(
[id] => 10202080
[patent_doc_number] => 20150087068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'METHODS OF GENETICALLY MODIFYING ANIMAL CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/494300
[patent_app_country] => US
[patent_app_date] => 2014-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7079
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14494300
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/494300 | Methods of genetically modifying animal cells | Sep 22, 2014 | Issued |
Array
(
[id] => 11083781
[patent_doc_number] => 20160280746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'POLYPEPTIDE EXHIBITING FLUORESCENT PROPERTIES, AND UTILIZATION OF THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/913483
[patent_app_country] => US
[patent_app_date] => 2014-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16680
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913483
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913483 | Polypeptide exhibiting fluorescent properties, and utilization of the same | Aug 21, 2014 | Issued |